Dr. Schuyler CV
PHONE 843-906-7187
EMAIL [email protected]
Walter B.J. Schuyler III, M.D.
Education
1998-2002
2002-2003
2004-2008
2008-2009
Furman University, Greenville SC
Bachelor of Arts, Political Science
University of Vermont, Burlington VT
Post-Baccalaureate Pre-Med
University of Vermont, Burlington VT
Doctor of Medicine
Maine Medical Center, Portland ME
Internship in Internal Medicine
Residener & Fellowship
2009 – 2012
2012-2013
Anesthesiology
Maine Medical Center, Portland ME
Fellow in Multidisciplinary Interventional Pain Medicine Fellowship
Northwestern University, Chicago IL
Professional Experience
Pain Specialists of Charleston, PA, and Clinical Trials of South Carolina
Physician and Sub-Investigator, July 2013 – November 30h, 2017
Relevant Affiliations
American Society of Anesthesiologists
Maine Society of Anesthesiologists
American Pain Society
American Society of Interventional Pain Physicians
Licensures and Certifications
Expired Medical License in the States of Illinois and Maine
South Carolina Board of Medical Examiners, June 2013 – Present
Board Certified in Anesthesiology, 2012 – Present
Board Certified in ABA Pain Medicine, 2013 – Present
Awards Received/Presentations/Leadership
Intern of the Year – Maine Medical Center (2008 – 2009)
Maine Medical Center Jay G. Hayden II, Anesthesia Book Award (2012)
2 Poster presentations at the ASA in San Diego (2010)
2 Poster presentations at the ASA in Chicago (2011)
Grand Rounds Case Presentation: Anesthetic Management of Tracheal Stenosis and
Tracheal Resection (2011) and Oncologic Pain Management: A Role For IV Lidocaine?
(2012)
Member of Maine Medical Center Patient Safety Committee (2010-11)
Personal
I have been happily married for over 9 years and enjoy spending time with my beautiful 4 year old daughter and one year old son. I also enjoy the outdoors and activities that include hiking, soccer, basketball, golf, tennis
References
Available on request
Clinical Research Experience
A Double-blind, Placebo-controlled, Crossover Study to Evaluate the Efficacy and Tolerability of 3VM1001 Cream for the Treatment of Pain Associated with Post-Herpetic Neuralgia: A Proof of Concept Study November 2017-present
Principal Investigator
A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects with Moderatelyto Severely Symptomatic Osteoarthritis November 2017- present
Sub-Investigator
“A Phase 1, Open-label Study of the Safety, Tolerability, and Pharmacokinetics of XXX Following Single Intradiscal Injection in Subjects with Degenerative Disc Disease” May 2017- Present
Sub-Investigator
A Double-blind, Placebo-controlled, Randomized Study to Assess the Safety and Efficacy of 3 VM1001 Cream for the Treatment of Chronic Pain caused by Osteoarthritis of the Knee: A Dose-Ranging Study
Sub-Investigator
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared with Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients with Influenza January 2017- April 2017
Sub-Investigator
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared with Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Patients with Influenza at High Risk of Influenza Complications January 2017-Present
Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients with Osteoarthritis of the Hip or Knee. September 2016-June 2017
Sub-Investigator
A Phase 2, 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis April 2017- Present
Sub-Investigator
A Safety and Efficacy Evaluation of XXXX Laxative in Adults Experiencing Non-Idiopathic Constipation. August 2016- January 2017
Principal Investigator
A Randomized Withdrawal, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of XXXX in Patients with Moderate-to-Severe Chronic Low Back Pain. May 2016-November 2017
Sub-Investigator
“A Double-blind Placebo-controlled, Randomized Study to Assess to Safety and Efficacy of XXXX Cream for the Treatment of Chronic Pain caused by Osteoarthritis of the Knee: A Proof of Concept Study” December 2015- May 2016
Sub-Investigator
“A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate The Efficacy and Safety of an Intra-Articular Injection of XXXX in Adults with Pain Due to Osteoarthritis o f the Knee” October 2015-January 2016
Sub-Investigator
“A Multicenter, Open-label Study of XXXX in Patients with Lumbar Disc Herniation” July 2015- October 2017
Sub-Investigator
“Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of XXXX as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee.” August 2015-2016
Sub-Investigator
“A Multicenter, Open-label Study of XXXX in Patients with Lumbar Disc Herniation” July 2015- November 2017
Sub-Investigator
“A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of XXXX or Combined with Hyaluronic Acid (HA) in Subjects with Chronic Discogenic Lumbar Back Pain Through 12 Months” February 2015- Present
Sub-Investigator
“An interventional Phase II/III randomized, double-blind trial investigating the efficacy and safety of intravenous XXXX in subjects with complex regional pain syndrome type I (CRPS-I)” August 2014-2016
Sub-Investigator
“A Phase 3 Multicenter, Randomized, Double-blind, Controlled, Comparative Study of XXXX in Patients with Lumbar Disc Herniation” January 2014-2014
Sub-Investigator
“A Prospective, Randomized, Multi-Center, Controlled Clinical Trial to Assess the Safety and Efficacy of the XXXX in the Treatment of Chronic Pain.” January 2014-2015
Sub-Investigator
“The XXXX Study is a Randomized, Prospective, Multicenter, Clinical Study Designed to Demonstrate the Safety and Efficacy of the Prodigy Neurostimulation System Using Tonic and Burst Stimulation Therapy to Manage Patients with Chronic Intractable Pain” November 2013- November 2016
Sub-Investigator